{"id":"https://openalex.org/W4362531794","doi":"https://doi.org/10.1158/2159-8290.22532195","title":"Supplementary Figure 6 from AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer","display_name":"Supplementary Figure 6 from AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362531794","doi":"https://doi.org/10.1158/2159-8290.22532195"},"language":"en","primary_location":{"id":"doi:10.1158/2159-8290.22532195","doi":"https://doi.org/10.1158/2159-8290.22532195","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.22532195","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_6_from_AZD9291_an_Irreversible_EGFR_TKI_Overcomes_T790M-Mediated_Resistance_to_EGFR_Inhibitors_in_Lung_Cancer/22532195/1/files/39995414.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_6_from_AZD9291_an_Irreversible_EGFR_TKI_Overcomes_T790M-Mediated_Resistance_to_EGFR_Inhibitors_in_Lung_Cancer/22532195/1/files/39995414.pdf","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026352956","display_name":"Darren A.E. Cross","orcid":"https://orcid.org/0000-0002-5227-2871","observed_orcids":["https://orcid.org/0000-0002-5227-2871"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Darren A.E. Cross","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109386587","display_name":"Susan E. Ashton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan E. Ashton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046261528","display_name":"Serban Ghiorghiu","orcid":"https://orcid.org/0009-0006-6879-9113","observed_orcids":["https://orcid.org/0009-0006-6879-9113"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Serban Ghiorghiu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032576859","display_name":"Cath Eberlein","orcid":"https://orcid.org/0000-0002-7357-7789","observed_orcids":["https://orcid.org/0000-0002-7357-7789"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cath Eberlein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037844360","display_name":"Caroline A. Nebhan","orcid":"https://orcid.org/0000-0002-9402-7284","observed_orcids":["https://orcid.org/0000-0002-9402-7284"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caroline A. Nebhan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048353122","display_name":"Paula J. Spitzler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paula J. Spitzler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072499136","display_name":"Jonathon P. Orme","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathon P. Orme","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019998609","display_name":"M. Raymond V. Finlay","orcid":"https://orcid.org/0000-0003-1402-193X","observed_orcids":["https://orcid.org/0000-0003-1402-193X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Raymond V. Finlay","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084047203","display_name":"Richard A. Ward","orcid":"https://orcid.org/0000-0002-2310-9477","observed_orcids":["https://orcid.org/0000-0002-2310-9477"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard A. Ward","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112905629","display_name":"Martine J. Mellor","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martine J. Mellor","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Gareth Hughes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gareth Hughes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025708687","display_name":"Amar Rahi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amar Rahi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111628033","display_name":"Vivien N. Jacobs","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vivien N. Jacobs","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086276533","display_name":"Monica Red Brewer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monica Red Brewer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050389295","display_name":"Eiki Ichihara","orcid":"https://orcid.org/0000-0002-2966-106X","observed_orcids":["https://orcid.org/0000-0002-2966-106X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eiki Ichihara","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107791204","display_name":"Jing Sun","orcid":"https://orcid.org/0000-0002-9820-5754","observed_orcids":["https://orcid.org/0000-0002-9820-5754"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jing Sun","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061753589","display_name":"Hailing Jin","orcid":"https://orcid.org/0000-0001-5778-5193","observed_orcids":["https://orcid.org/0000-0001-5778-5193"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hailing Jin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089604553","display_name":"Peter G. Ballard","orcid":"https://orcid.org/0000-0003-2024-5219","observed_orcids":["https://orcid.org/0000-0003-2024-5219"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Ballard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069468694","display_name":"Katherine J. Al-Kadhimi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katherine Al-Kadhimi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032382796","display_name":"Rachel A. Rowlinson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachel Rowlinson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059691963","display_name":"Teresa C. M. Klinowska","orcid":"https://orcid.org/0000-0003-1997-7340","observed_orcids":["https://orcid.org/0000-0003-1997-7340"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Teresa Klinowska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070457926","display_name":"Graham H.P. Richmond","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Graham H.P. Richmond","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070927117","display_name":"Mireille Cantarini","orcid":"https://orcid.org/0000-0002-9593-9541","observed_orcids":["https://orcid.org/0000-0002-9593-9541"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mireille Cantarini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100638261","display_name":"Dong\u2010Wan Kim","orcid":"https://orcid.org/0000-0001-5124-7132","observed_orcids":["https://orcid.org/0000-0001-5124-7132"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dong-Wan Kim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055792960","display_name":"Malcolm Ranson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Malcolm R. Ranson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5062616992","display_name":"William J. Pao","orcid":"https://orcid.org/0000-0002-9888-0733","observed_orcids":["https://orcid.org/0000-0002-9888-0733"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William Pao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/osimertinib","display_name":"osimertinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.8889999985694885},{"id":"https://openalex.org/keywords/egfr-t790m-mutation","display_name":"T790M mutation","score":0.9039999842643738},{"id":"https://openalex.org/keywords/egfr-inhibitor-resistance","display_name":"EGFR inhibitor resistance","score":0.8569999933242798},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.9179999828338623},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.9509999752044678},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.6899999976158142},{"id":"https://openalex.org/keywords/a431","display_name":"A431","score":0.8920000195503235},{"id":"https://openalex.org/keywords/h1975","display_name":"H1975","score":0.9980000257492065}],"concepts":[{"id":"https://openalex.org/C2777930144","wikidata":"https://www.wikidata.org/wiki/Q25100112","display_name":"T790M","level":5,"score":0.9304989576339722},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6452974081039429},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.5399977564811707},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.507080078125},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4797869324684143},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.442261278629303},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3420446515083313},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32948505878448486},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.2605252265930176},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.23696014285087585},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22484615445137024},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.07817348837852478}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2159-8290.22532195","doi":"https://doi.org/10.1158/2159-8290.22532195","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.22532195","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_6_from_AZD9291_an_Irreversible_EGFR_TKI_Overcomes_T790M-Mediated_Resistance_to_EGFR_Inhibitors_in_Lung_Cancer/22532195/1/files/39995414.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2159-8290.22532195","doi":"https://doi.org/10.1158/2159-8290.22532195","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.22532195","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_6_from_AZD9291_an_Irreversible_EGFR_TKI_Overcomes_T790M-Mediated_Resistance_to_EGFR_Inhibitors_in_Lung_Cancer/22532195/1/files/39995414.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362531794.pdf","grobid_xml":"https://content.openalex.org/works/W4362531794.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2088540000","https://openalex.org/W4392689755","https://openalex.org/W2066659324","https://openalex.org/W2265752705","https://openalex.org/W4254467096","https://openalex.org/W1904060183","https://openalex.org/W2339276903","https://openalex.org/W1937437568","https://openalex.org/W7098745884","https://openalex.org/W2260046511"],"abstract_inverted_index":{"PDF":[0],"file":[1],"-":[2],"312KB,":[3],"Efficacy":[4],"of":[5],"AZD9291":[6,20],"in":[7,21],"H3255,":[8],"PC-9VanR":[9],"and":[10,23],"A431":[11],"xenograft":[12,25],"models.":[13,26],"Weight":[14],"loss":[15],"data":[16],"for":[17],"chronically":[18],"dosed":[19],"PC-9":[22],"H1975":[24]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2023-04-06T00:00:00"}